Davis Matthew W. - Insider Non-Derivative Transactions at Aquestive Therapeutics, Inc. (AQST) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Nov 10, 2025, Davis Matthew W.'s relationship to Aquestive Therapeutics, Inc. (AQST) is Officer (Chief Development Officer), and currently has 50,000 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AQST insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Davis Matthew W. - Insider Non-Derivative Transactions of AQST Common Stock

Davis Matthew W. - Insider Non-Derivative Transactions at AQST

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 11, 2025	Acquisition -- (Common Stock)	50000	0	50000